Iovance Biotherapeutics, Inc.
DE ˙ DB ˙ US4622601007
3,31 € ↓ -0,17 (-4,89%)
2026-06-04
DEL PRIS
SecurityDE:2LB / Iovance Biotherapeutics, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership168,677 shares
Latest Disclosed Value $ 460,488
Group One Trading, L.p. ownership in 2LB / Iovance Biotherapeutics, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 168,677 shares of Iovance Biotherapeutics, Inc. (DE:2LB) valued at $394,789 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 429,854 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of -60.76% during the quarter. The current value of the position is $558,321 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (2LB) in the form of stock options. The firm currently holds call options representing 1,173,400 of underlying shares valued at $3,203,382 USD and put options representing 191,300 of underlying shares valued at $522,249 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:2LB / Iovance Biotherapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 168,677 -261,177 -60.76 460 -50.64 0.0008
2025-11-12 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 429,854 -123,614 -22.33 933 -2.00 0.0016
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 553,468 77,667 16.32 952 -39.96 0.0021
2025-05-14 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 475,801 -1,220,500 -71.95 1,584 -87.38 0.0046
2025-05-14 2024-12-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,696,301 413,333 32.22 12,553 4.19 0.0287
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,696,301 413,333 12,553 0.0310
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,282,968 551,361 75.36 12,047 105.33 0.0343
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 731,607 243,569 49.91 5,867 -18.87 0.0227
2024-05-10 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 488,038 -88,264 -15.32 7,233 54.36 0.0278
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 576,302 -49,399 -7.89 4,685 64.62 0.0123
2023-11-09 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 625,701 523,723 513.56 2,847 296.93 0.0096
2023-08-09 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 101,978 41,747 69.31 718 94.84 0.0023
2023-05-12 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 60,231 -70,444 -53.91 368 -55.93 0.0013
2023-02-09 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 130,675 65,137 99.39 835 32.96 0.0019
2022-11-09 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 65,538 -54,984 -45.62 628 -52.82 0.0012
2022-08-11 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 120,522 119,451 11,153.22 1,331 7,294.44 0.0021
2022-05-12 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,071 -31,864 -96.75 18 -97.14 0.0000
2022-02-11 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 32,935 -126,809 -79.38 629 -84.03 0.0005
2021-11-12 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 159,744 159,744 3,939 0.0043
2021-08-10 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -14,035 -100.00 0 -100.00
2021-05-12 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 14,035 14,035 444 0.0007
2021-02-10 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -46,117 -100.00 0 -100.00
2020-11-12 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 46,117 32,483 238.25 1,518 354.49 0.0048
2019-08-09 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 13,634 13,634 334 0.0030
2019-05-14 2019-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 0 -15,403 -100.00 0 -100.00
2019-02-05 2018-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 15,403 15,403 136 0.0012
2018-11-08 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -7,045 -100.00 0 -100.00
2018-08-13 2018-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 7,045 7,045 90 0.0008
2018-02-09 2017-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -122 -100.00 0 -100.00
2017-11-15 2017-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 122 -4,080 -97.10 1 -96.77 0.0000
2017-08-14 2017-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 4,202 -1,398 -24.96 31 -26.19 0.0003
2017-05-10 2017-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 5,600 1,316 30.72 42 40.00 0.0005
2017-02-15 2016-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 4,284 -12,346 -74.24 30 -78.10 0.0003
2016-11-14 2016-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 16,630 -1,042 -5.90 137 -4.20 0.0015
2016-08-12 2016-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 17,672 11,918 207.13 143 393.10 0.0017
2016-05-12 2016-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 5,754 5,754 0.00 29 0.0004
2016-02-11 2015-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 0 -45,978 -100.00 0 -100.00
2015-11-20 2015-09-30 13F/A-1 LION BIOTECHNOLOGIES COM 53619R102 45,978 12,472 37.22 265 -13.68 0.0037
2015-11-06 2015-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 45,978 265
2015-08-11 2015-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 33,506 33,506 307 0.0043
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 1,173,400 65.13 3,203 107.72 n/a n/a n/a
2025-11-12 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 710,600 30.58 1,542 64.74 n/a n/a n/a
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 544,200 -0.78 936 -48.74 n/a n/a n/a
2025-05-14 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 548,500 -33.35 1,827 -70.01 n/a n/a n/a
2025-05-14 2024-12-31 13F/A IOVANCE BIOTHERAPEUTICS COM Call 822,900 27.52 6,089 0.50 n/a n/a n/a
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 822,900 6,089 n/a n/a n/a
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 645,300 98.13 6,059 131.97 n/a n/a n/a
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 325,700 -78.13 2,612 -88.16 n/a n/a n/a
2024-05-10 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 1,489,100 41.03 22,068 157.08 n/a n/a n/a
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 1,055,900 30.09 8,584 132.44 n/a n/a n/a
2023-11-09 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 811,700 74.82 3,693 13.00 n/a n/a n/a
2023-08-09 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 464,300 59.66 3,269 84.01 n/a n/a n/a
2023-05-12 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 290,800 -46.62 1,777 -48.98 n/a n/a n/a
2023-02-09 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 544,800 134.42 3,481 56.38 n/a n/a n/a
2022-11-09 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 232,400 -22.38 2,226 -32.65 n/a n/a n/a
2022-08-11 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 299,400 -26.11 3,305 -51.02 n/a n/a n/a
2022-05-12 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 405,200 73.61 6,747 51.41 n/a n/a n/a
2022-02-11 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 233,400 178.52 4,456 115.58 n/a n/a n/a
2021-11-12 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 83,800 -86.02 2,067 -86.75 n/a n/a n/a
2021-08-10 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 599,400 384.95 15,596 298.57 n/a n/a n/a
2021-05-12 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 123,600 -37.35 3,913 -57.26 n/a n/a n/a
2021-02-10 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 197,300 116.58 9,155 205.27 n/a n/a n/a
2020-11-12 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 91,100 -71.93 2,999 -66.33 n/a n/a n/a
2020-08-13 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 324,500 5.19 8,908 -3.54 n/a n/a n/a
2020-05-13 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 308,500 116.64 9,235 134.27 n/a n/a n/a
2020-02-10 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 142,400 -34.47 3,942 -0.33 n/a n/a n/a
2019-11-12 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 217,300 910.70 3,955 650.47 n/a n/a n/a
2019-08-09 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 21,500 115.00 527 454.74 n/a n/a n/a
2019-05-14 2019-03-31 13F/A IOVANCE BIOTHERAPEUTICS COM Call 10,000 -1.96 95 5.56 n/a n/a n/a
2019-05-13 2019-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 10,000 95 n/a n/a n/a
2019-02-05 2018-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 10,200 -57.32 90 -66.54 n/a n/a n/a
2018-11-08 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 23,900 168.54 269 135.96 n/a n/a n/a
2018-08-13 2018-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 8,900 -76.64 114 -82.30 n/a n/a n/a
2018-05-16 2018-03-31 13F/A IOVANCE BIOTHERAPEUTICS COM Call 38,100 20.19 644 153.54 n/a n/a n/a
2018-05-10 2018-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 38,100 644 n/a n/a n/a
2018-02-09 2017-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 31,700 254 n/a n/a n/a
2017-11-14 2017-09-30 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F IOVANCE BIOTHERAPEUTICS COM Call 24,000 176 n/a n/a n/a
2017-02-15 2016-12-31 13F LION BIOTECHNOLOGIES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F LION BIOTECHNOLOGIES COM Call 6,500 -67.50 54 -66.67 n/a n/a n/a
2016-08-12 2016-06-30 13F LION BIOTECHNOLOGIES COM Call 20,000 -67.37 162 -47.91 n/a n/a n/a
2016-05-12 2016-03-31 13F LION BIOTECHNOLOGIES COM Call 61,300 -46.13 311 -64.62 n/a n/a n/a
2016-02-11 2015-12-31 13F LION BIOTECHNOLOGIES COM Call 113,800 535.75 879 753.40 n/a n/a n/a
2015-11-20 2015-09-30 13F/A LION BIOTECHNOLOGIES COM Call 17,900 103 n/a n/a n/a
2015-11-06 2015-09-30 13F LION BIOTECHNOLOGIES COM Call 17,900 103 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 191,300 46.14 522 83.80 n/a n/a n/a
2025-11-12 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 130,900 15.53 284 46.39 n/a n/a n/a
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 113,300 -48.05 195 -73.28 n/a n/a n/a
2025-05-14 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 218,100 -76.70 726 -89.52 n/a n/a n/a
2025-05-14 2024-12-31 13F/A IOVANCE BIOTHERAPEUTICS COM Put 935,900 77.12 6,926 39.59 n/a n/a n/a
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 935,900 6,926 n/a n/a n/a
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 528,400 98.27 4,962 132.15 n/a n/a n/a
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 266,500 9.99 2,137 -40.47 n/a n/a n/a
2024-05-10 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 242,300 -20.43 3,591 45.05 n/a n/a n/a
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 304,500 -35.92 2,476 14.48 n/a n/a n/a
2023-11-09 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 475,200 275.06 2,162 142.65 n/a n/a n/a
2023-08-09 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 126,700 165.06 892 205.14 n/a n/a n/a
2023-05-12 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 47,800 -77.93 292 -78.90 n/a n/a n/a
2023-02-09 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 216,600 2,574.07 1,384 1,674.36 n/a n/a n/a
2022-11-09 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 8,100 -19.80 78 -30.36 n/a n/a n/a
2022-08-11 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 10,100 -63.93 112 -75.97 n/a n/a n/a
2022-05-12 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 28,000 -67.48 466 -71.65 n/a n/a n/a
2022-02-11 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 86,100 6.69 1,644 -17.39 n/a n/a n/a
2021-11-12 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 80,700 -35.02 1,990 -38.43 n/a n/a n/a
2021-08-10 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 124,200 411.11 3,232 320.29 n/a n/a n/a
2021-05-12 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 24,300 -56.91 769 -70.62 n/a n/a n/a
2021-02-10 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 56,400 -6.16 2,617 32.31 n/a n/a n/a
2020-11-12 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 60,100 -51.45 1,978 -41.79 n/a n/a n/a
2020-08-13 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 123,800 28.69 3,398 17.99 n/a n/a n/a
2020-05-13 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 96,200 170.22 2,880 192.39 n/a n/a n/a
2020-02-10 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 35,600 226.61 985 397.47 n/a n/a n/a
2019-11-12 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 10,900 7.92 198 -20.16 n/a n/a n/a
2019-08-09 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 10,100 248 n/a n/a n/a
2019-05-14 2019-03-31 13F/A IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-05 2018-12-31 13F IOVANCE BIOTHERAPEUTICS COM Put 15,700 139 n/a n/a n/a
2018-11-08 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-13 2018-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 21,800 52.45 279 15.29 n/a n/a n/a
2018-05-16 2018-03-31 13F/A IOVANCE BIOTHERAPEUTICS COM Put 14,300 242 n/a n/a n/a
2018-05-10 2018-03-31 13F IOVANCE BIOTHERAPEUTICS COM Put 14,300 242 n/a n/a n/a
2017-11-14 2017-09-30 13F IOVANCE BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F IOVANCE BIOTHERAPEUTICS COM Put 5,000 37 n/a n/a n/a
2017-05-10 2017-03-31 13F LION BIOTECHNOLOGIES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-15 2016-12-31 13F LION BIOTECHNOLOGIES COM Put 27,000 -28.95 188 -39.94 n/a n/a n/a
2016-11-14 2016-09-30 13F LION BIOTECHNOLOGIES COM Put 38,000 11.44 313 13.41 n/a n/a n/a
2016-08-12 2016-06-30 13F LION BIOTECHNOLOGIES COM Put 34,100 -27.91 276 15.00 n/a n/a n/a
2016-05-12 2016-03-31 13F LION BIOTECHNOLOGIES COM Put 47,300 1,956.52 240 1,233.33 n/a n/a n/a
2016-02-11 2015-12-31 13F LION BIOTECHNOLOGIES COM Put 2,300 -95.82 18 -94.32 n/a n/a n/a
2015-11-20 2015-09-30 13F/A LION BIOTECHNOLOGIES COM Put 55,000 57.14 317 -1.25 n/a n/a n/a
2015-11-06 2015-09-30 13F LION BIOTECHNOLOGIES COM Put 55,000 317 n/a n/a n/a
2015-08-11 2015-06-30 13F LION BIOTECHNOLOGIES COM Put 35,000 321 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.